.png)
NEW ORLEANS — For people with type 2 diabetes (T2D) inadequately controlled on submaximal dulaglutide (Trulicity) doses, switching to tirzepatide (Mounjaro) produces significantly greater A1c and weight lowering than does escalating dulaglutide treatment. “Often, when we are with a patient who is not meeting treatment goals...
Axis Mundi Systems LLC 3773 Howard Ave Las Vegas, NV
Toll Free: 877-749-7128 ext. 500
office@cruisewithbruce.com
Copyright © 2023 virtualluxurytravelnews. All Rights Reserved
